a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.
Industry Biotechnology
A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with BPMC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then BPMC could also see price increases.
Ticker / NAME | Correlation To BBIO | 1D Price Change % | ||
---|---|---|---|---|
BBIO | 100% | +8.84% | ||
BPMC - BBIO | 48% Loosely correlated | +3.65% | ||
ARGX - BBIO | 46% Loosely correlated | +1.58% | ||
AXON - BBIO | 44% Loosely correlated | +0.55% | ||
ARRY - BBIO | 43% Loosely correlated | +2.60% | ||
RYTM - BBIO | 43% Loosely correlated | +2.68% | ||
More |